Table 3.

Treatment discontinuations and adverse events in treatment groups

	Placebo group (n=4)	Group 1 (n=6)	Group 2 (n=6)
Discontinuation of therapy due to an adverse event	0	0	0
Serious adverse events	0	0	0
Common adverse events
Nausea	1 (25%)	2 (33%)	6 (100%)
Diarrhoea	0	3 (50%)	6 (100%)
Decreased appetite	0	1 (17%)	5 (83%)
Abdominal bloating/dyspepsia	1 (25%)	1 (17%)	6 (100%)
Vomiting	0	0	3 (50%)
Weight loss >2 kg	0	1 (17%)	6 (100%)
Headache	1 (25%)	1 (17%)	1 (17%)
Testicular pain	0	1 (17%)	0
Lightheadedness	1 (25%)	0	0
Fatigue	0	1 (17%)	1 (17%)
Data are n (%).